15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 18 firms covering Tenet Healthcare Corporation, 17 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $224.00 to $308.00, so the covering firms are broadly aligned. The average target of $265.35 sits 2% above the current $259.20. The rating mix has stayed broadly stable, with Buy-side ratings easing from 17 to 16 over recent months. On the fundamentals, the Street sees consensus EPS building from about $5.68 next quarter toward $21.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS18 ratings
Strong Buy
Strong Buy00%
Buy1794%
Hold16%
Sell00%
Strong Sell00%
Based on 18 analysts giving stock ratings to Tenet Healthcare Corporation.
As of Sep, 16 of 17 firms rate THC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
THC EPS & revenue forecast
EPS · NEXT QUARTER
$5.68
Range $5.18 – $6.59 · 19 analysts · +21% YoY
Next period, 19 analysts expect Tenet Healthcare Corporation to earn $5.68 a share (range $5.18 – $6.59), versus $4.70 a year earlier. Full-year consensus is $21.22, growing to $21.08 the year after.
REVENUE · NEXT QUARTER
$5.8B
Range $5.7B – $6.2B · 19 analysts · +4% YoY
Revenue is expected to reach $5.8B (range $5.7B – $6.2B), +4.3% year-over-year. Full-year consensus is $22.4B, rising to $22.5B next year.
Top analysts covering Tenet Healthcare Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on THC.
#1
DM
David Macdonald
Truist Securities · Rank #109
Buy
$290.00+11.9% to target
Overall win rate
48%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #149
Buy
$283.00+9.2% to target
Overall win rate
44%
+ Follow
#3
Brian Tanquilut
Jefferies · Rank #208
Buy
$265.00+2.2% to target
Overall win rate
42%
+ Follow
#4
Jason Cassorla
Guggenheim
Buy
$283.00+9.2% to target
Coverage
—
+ Follow
#5
Stephen Baxter
Wells Fargo
Buy
$281.00+8.4% to target
Coverage
—
+ Follow
THC stock forecast FAQ
What is THC's average 12-month price target?+
The 17 analysts with a live target average $265.35 for Tenet Healthcare Corporation over the next 12 months, ranging from a $308.00 high to a $224.00 low.
Is THC stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 18 analyst ratings, 17 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for THC?+
The Street-high target is $308.00 (UBS), and the Street-low is $224.00 (Goldman Sachs). The average of all 17 active targets is $265.35.
How many Wall Street analysts cover THC?+
18 analysts have an active rating on Tenet Healthcare Corporation, and 17 firms carry a live 12-month price target.
Who is the most accurate analyst covering THC?+
Among analysts who currently cover THC, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #109). Their current call is Buy with a $290.00 target.
What is Tenet Healthcare Corporation's projected EPS for next quarter?+
The consensus estimate is $5.68 per share (range $5.18 – $6.59) across 19 analysts. Full-year EPS is projected at $21.22, rising to $21.08 the following year.
How much revenue is Tenet Healthcare Corporation expected to report next quarter?+
Consensus revenue is $5.8B (range $5.7B – $6.2B). Full-year revenue is projected at $22.4B, growing to $22.5B next year.
Have analysts been upgrading or downgrading THC lately?+
As of Sep, 16 of 17 firms rate THC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their THC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
